Pharma Llc Bridgebio serves as Executive at Eidos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Pharma Llc Bridgebio has executed 15 insider transactions totaling $62.9M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 10, 2018 involved selling 2,664 shares valued at $37.2K.
Pharma Llc Bridgebio currently holds 22,589,300 shares of Eidos Therapeutics, Inc. (EIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pharma Llc Bridgebio has been a net buyer of EIDX stock. They have purchased $61.2M and sold $1.6M worth of shares.
Pharma Llc Bridgebio's most recent insider trade was on Dec 10, 2018, when they sold 2,664 shares at $13.96 per share.
Get notified when new Form 4 filings are submitted
| $13.29 |
| Discretionary |
| Dec 10, 2018 | EIDX | $504.9K | Purchase | 37,989 | $13.29 | Discretionary |
| Dec 10, 2018 | EIDX | $37.2K | Purchase | 2,664 | $13.96 | Discretionary |
| Dec 7, 2018 | EIDX | $506.2K | Sale | 36,314 | $13.94 | Discretionary |
| Dec 7, 2018 | EIDX | $69.8K | Sale | 4,860 | $14.36 | Discretionary |
| Dec 7, 2018 | EIDX | $506.2K | Purchase | 36,314 | $13.94 | Discretionary |
| Dec 7, 2018 | EIDX | $69.8K | Purchase | 4,860 | $14.36 | Discretionary |
| Dec 6, 2018 | EIDX | $519.9K | Sale | 38,970 | $13.34 | Discretionary |
| Dec 6, 2018 | EIDX | $519.9K | Purchase | 38,970 | $13.34 | Discretionary |
| Dec 5, 2018 | EIDX | $15.5M | Purchase | 1,103,848 | $14.01 | Discretionary |
| Dec 3, 2018 | EIDX | $27.1M | Purchase | 1,750,000 | $15.50 | Discretionary |
| Jun 22, 2018 | EIDX | $17.0M | Purchase | 1,000,000 | $17.00 | Discretionary |
| Jun 22, 2018 | EIDX | $3.6M | Payment | 211,762 | $17.00 | Discretionary |
| Jun 22, 2018 | EIDX | $0 | Conversion | 18,826,417 | $N/A | Discretionary |